Eiger BioPharmaceuticals, Inc.
(NASDAQ : EIGR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 5.02%152.060.0%$1895.16m
NVAXNovavax, Inc. -2.52%233.8992.9%$1460.03m
OCGNOcugen, Inc. -8.85%8.140.0%$881.78m
AMGNAmgen, Inc. -0.83%228.091.3%$593.30m
ILMNIllumina, Inc. -3.09%446.803.5%$552.42m
REGNRegeneron Pharmaceuticals, Inc. -0.68%455.502.7%$529.33m
VRTXVertex Pharmaceuticals, Inc. -1.82%213.101.9%$509.48m
GILDGilead Sciences, Inc. -1.02%63.061.0%$495.28m
BNGOBioNano Genomics, Inc. -6.81%10.430.0%$451.19m
ALXNAlexion Pharmaceuticals, Inc. -0.14%154.272.0%$390.85m
BIIBBiogen, Inc. -1.26%279.181.7%$379.88m
CRSPCRISPR Therapeutics AG -2.86%129.700.6%$309.74m
SRNESorrento Therapeutics, Inc. -3.24%10.621.3%$257.45m
EXASEXACT Sciences Corp. -3.01%130.7618.4%$251.65m
VXRTVaxart, Inc. 7.08%7.860.0%$238.64m

Company Profile

Eiger BioPharmaceuticals, Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization drugs for life-threatening, rare and ultra-rare diseases with high unmet medical needs and no approved therapies. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.